Back to Search
ELEFTHERIOS MYLONAKIS, MD PHD
MD PHD
Infectious Disease Physician
NPI: 1629041074IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
U1976(TX)MD13901(RI)
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
OTHER
Class of 1990
Research & Publications (20)
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
PMID 19332683·Antimicrob Agents Chemother·2009
7-preclinical
Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients.
PMID 19366563·Curr Infect Dis Rep·2009
8-other
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.
PMID 19454492·Haematologica·2009
1-meta
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.
PMID 19237602·J Exp Med·2009
7-preclinical
Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model.
PMID 19666778·Eukaryot Cell·2009
7-preclinical
The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii.
PMID 19651856·Infect Immun·2009
7-preclinical
Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium.
PMID 19329669·Eukaryot Cell·2009
7-preclinical
Antifungal drug discovery through the study of invertebrate model hosts.
PMID 19442135·Curr Med Chem·2009
6-review
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.
PMID 19196973·Proc Natl Acad Sci U S A·2009
7-preclinical
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
PMID 19125671·J Infect Dis·2009
7-preclinical
A nuclear receptor-like pathway regulating multidrug resistance in fungi.
PMID 18385733·Nature·2008
7-preclinical
Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.
PMID 18794525·Proc Natl Acad Sci U S A·2008
7-preclinical
Epidemiology and management of cryptococcal meningitis: developments and challenges.
PMID 18312157·Expert Opin Pharmacother·2008
6-review
A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds.
PMID 19180076·Nat Protoc·2008
7-preclinical
Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host.
PMID 18060516·Mycopathologia·2008
6-review
Posaconazole: a new broad-spectrum antifungal agent.
PMID 17516880·Expert Opin Pharmacother·2007
6-review
Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity.
PMID 17548495·Antimicrob Agents Chemother·2007
8-other
Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi.
PMID 17676994·PLoS Pathog·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6550 FANNIN ST STE 1001
HOUSTON, TX 77030 - Phone
- (617) 670-9115
Quick Facts
- NPI
- 1629041074
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile